Testosterone Propionate

丙酸睾酮

Report date: 2023/02/23 20:00:33
NME

Base Information

Drug NameTestosterone Propionate
Drug Alias Name丙酸睾丸素丙酸睾丸酮丙酸睾丸甾酮TestovironSynandrol +[7
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsPuberty, DelayedHypogonadismVaginitis +[5
Global Approved IndicationsPuberty, DelayedHypogonadismBreast Neoplasms
Approved Indications in ChinaPuberty, DelayedHypogonadismBreast Neoplasms
Original Approved Country/TerritoryUnited Kingdom
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUniversity Of Vermont
China Registration ClassN/A

Develop Information

Inactive CompaniesUniversity Of Vermont
Active IndicationsPuberty, DelayedHypogonadismBreast Neoplasms
Inactive IndicationsVaginitisDyspareunia

Other Information

ATC CodeG03BA03